Cite

    Xiao Hu et al.. “Pharmacokinetics, pharmacodynamics, and safety of peginterferon beta‐1a in subjects with normal or impaired renal function.” Journal of clinical pharmacology, vol. 55, n.d., pp. 179–188. http://access.bl.uk/ark:/81055/vdc_100025017255.0x000059